Catalyst Calendar • Endpoint Arena

Catalyst Calendar

Mon, Aug 10, 2026

1 updates

6:30 AM

Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

Enrollment • Phase 2Enrollment milestone Mon, Aug 10, 2026, 6:30 AM EDTverupharma.com

Tue, Aug 4, 2026

1 updates

8:30 AM

Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss

verupharma.com

Mon, Aug 3, 2026

1 updates

8:30 AM

Veru to Report Fiscal 2026 Third Quarter Financial Results on August 10th

verupharma.com

Thu, Jul 30, 2026

1 updates

8:30 AM

Veru to Participate in Fireside Chat at the Canaccord Genuity's 46th Annual Growth Investors Conference

verupharma.com

Mon, Jul 27, 2026

1 updates

8:10 AM

Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Enrollment • Phase 2oral presentation Mon, Jul 27, 2026verupharma.com

Tue, Jul 7, 2026

1 updates

8:30 AM

Veru to Present at 2026 Obesity & Weight Loss Drug Development Summit and Pre-Conference Workshop Day

verupharma.com